3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Personality disorders are chronic mental disorders


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Prostate Cancer -

Surgery offers best survival for prostate cancer

Prostate CancerOct 09, 07

Removal of the prostate gland, a surgical procedure also known as “prostatectomy,” offers longer survival rates than radiation therapy, careful monitoring, or hormone therapy for men with “localized” prostate cancer, a common form of the disease in which the cancer has not yet spread to other organs, new research shows.

“We observed that prostatectomy was associated with the best long term prognosis—in particular, for younger patients and patients with (aggressive) tumors,” senior author Dr. Christine Bouchardy, from Geneva University, Switzerland, told Reuters Health. “We are not very surprised that prostatectomy offers the best chance of cure at long term, but we should wait for results from (clinical) trials to confirm this.”

The study, which is reported in the Archives of Internal Medicine, involved 844 men with localized prostate cancer, including 158 who underwent prostatectomy, 205 had radiation therapy, 378 had careful monitoring and treatment if needed, 72 received hormone therapy, and 31 had other types of therapy.

In general, the type of therapy had little impact on the 5-year survival rate from prostate cancer. The exception was treatment with hormone therapy alone, which resulted in a worse 5-year survival than the other therapies.

At 10 years, however, the survival differences emerged between the groups. Patients treated with radiation therapy or followed with careful monitoring had prostate cancer-related survival rates of 75 and 72 percent, respectively, whereas for those treated with surgery it was 83 percent.

Further analysis showed that the inferior survival seen with radiation therapy and close monitoring was largely confined to patients younger than 70 years or those with aggressive cancers.

“According to this study, surgery appears to offer prostate cancer patients the best survival chances at long term,” Bouchardy said. “Given the lack of consensus on the best treatment for patients and the important therapeutic disparities in routine health care practice, results of this study can help patients and practitioners in their decision making.”

SOURCE: Archives of Internal Medicine, October 8, 2007.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Prostate cancer not warded off by supplements
  Prostate cancer hormone therapy may raise mortality
  Men with Health Risk Behaviors Unaware of PSA Test
  Too much calcium in blood may increase risk of fatal prostate cancer
  Racial differences again seen in prostate cancer
  Obesity ups a woman’s pancreatic cancer risk: study
  Elevated biomarkers predict risk for prostate cancer recurrence
  Healthy lifestyle triggers genetic changes: study
  Dehydrated Tomatoes Show Promise for Preventing Prostate Cancer
  Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer
  New analysis boosts drug’s prostate cancer value
  Legislation needed to provide coverage for ED treatment after prostatectomy

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site